Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Brainomix has introduced its Brainomix 360 Stroke Next Generation platform at the International Stroke Conference, featuring a new net water uptake capability to enhance stroke assessment using routine CT scans.
Ginkgo Bioworks, in collaboration with OpenAI, demonstrated an autonomous laboratory system powered by GPT-5 that reduced protein synthesis costs by 40% compared to existing methods.
HealthTrackRx has chosen SYNERGEN Health as its revenue cycle management partner to improve operational efficiency and financial performance through AI-enabled technology.
Cognizant and Uniphore have announced a strategic partnership to develop domain-specific AI solutions that combine small language models and AI agents tailored for enterprise workflows. The collaboration will initially target the Life Sciences and Banking and Capital Markets sectors.
Presbyterian Healthcare Services is expanding the GW RhythmX AI Precision Care Platform across its 200 primary care clinicians after a successful pilot that improved efficiency and patient care insights.
Deep EigenMatics has secured the top global ranking for new U.S. patent families in AI drug discovery methods for 2025, surpassing all major pharmaceutical companies in patent output during its first year of operation.
Virtual Science AI has introduced Medical Congress AI, a conversational AI solution that captures and analyzes real-time insights from medical congress events, marking a first in the life sciences industry.
Oracle has introduced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to unify and analyze large-scale health data to support pharmaceutical, medical device, and research organizations.
XtalPi unveiled its new AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, aiming to accelerate systematic discovery of molecular glue therapeutics.
Nucs AI has established a Medical Advisory Board to guide the clinical integration of its AI-based imaging technology in cancer care. The board includes experts from institutions such as UCLA, AstraZeneca, and the European Institute of Oncology.
Healthcare Triangle, Inc. has entered a collaboration with Better.care to extend digital health and data platform services across Europe, Southeast Asia, the Middle East, and Africa. The agreement includes workforce enablement programs and positions Healthcare Triangle as a preferred service provider in multiple markets.
Viveka Health has achieved the HITRUST e1 Certification, confirming the effectiveness of its foundational cybersecurity controls. The certification process was conducted in collaboration with Palindrome Technologies, a HITRUST Authorized External Assessor.
EyeContactDX has named developmental-behavioral pediatrician Dr. Carol Weitzman as Senior Strategic Advisor to support the expansion of its AI-based eye-tracking autism screening tool in primary care.
EQT Life Sciences and Gimv have co-led a €51 million Series B funding round for Exciva to advance its lead candidate, Deraphan, into Phase 2 clinical trials targeting agitation in Alzheimer’s disease.
OpenAI has launched ChatGPT Health, a dedicated feature that allows users to discuss health and wellness topics in a secure environment. The new section separates health-related chats from other conversations and supports integrations with apps like Apple Health, Function, and MyFitnessPal.
iScribeHealth has been selected by Lifepoint Health to provide AI-powered scribing technology that captures and integrates clinical notes in real time, reducing documentation tasks for physicians.
SENA Health has reported a 300% year-over-year growth driven by increased adoption of its AI-powered Command Center, which streamlines patient access and administrative workflows for healthcare organizations.
CAQH announced that twelve major health plans have become its shareholders, a move aimed at strengthening partnerships and accelerating the development of connected healthcare data solutions.
Siemens CEO Roland Busch said the company is exploring potential acquisitions in artificial intelligence, life sciences, and operations software, building on its $5.1 billion purchase of Dotmatics last year to strengthen AI-driven drug development and data infrastructure.
Biobeat Technologies has raised $50 million in Series B funding led by Ally Bridge Group, OrbiMed Advisors, and Elevage Medical to expand commercialization of its FDA-cleared, cuff-less 24-hour ambulatory blood pressure monitoring system in the U.S.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
